Your browser doesn't support javascript.
loading
A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy.
Felip, Enriqueta; Rojo, Federico; Reck, Martin; Heller, Astrid; Klughammer, Barbara; Sala, Gemma; Cedres, Susana; Peralta, Sergio; Maacke, Heiko; Foernzler, Dorothee; Parera, Marta; Möcks, Joachim; Saura, Cristina; Gatzemeier, Ulrich; Baselga, José.
Affiliation
  • Felip E; Medical Oncology Service and Pathology Service, Vall d'Hebron University Hospital, Barcelona, Spain.
Clin Cancer Res ; 14(12): 3867-74, 2008 Jun 15.
Article in En | MEDLINE | ID: mdl-18559607
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Antineoplastic Combined Chemotherapy Protocols / Platinum Compounds / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Spain Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Antineoplastic Combined Chemotherapy Protocols / Platinum Compounds / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Spain Country of publication: United States